产品档案由注册证、说明书原文与平台整理数据生成
RESTYLANEP020023
RESTYLANE是一款玻尿酸填充产品,注册人 Q-Med AB。库里关联的注册证:美国 P020023。美国首次批准于 2003-12-12(P020023)。数据截至 2026-10-19。
- 监管属性玻尿酸填充 · 监管属性未定
- 注册人Q-Med AB
- 辖区US
- 档案更新于2026-10-19 · v1
注册与基本资料公开可看;交叉发现与价格需要登录
注册与基本资料
说明书对照(分辖区)
同一属性在不同辖区说明书里的原文;没写的标「原文未报告」,不适用的标「不适用」
暂无数据
注册时间线
- US
P020023 首次批准
- US
P020023 · P020023/S007
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|CHANGE IN THE CLEANING PROCESS.
- US
P020023 · P020023/S008
Special (Immediate Track)|Labeling Change - Indications/instructions/shelf life/tradename|APPROVAL FOR THE PRODUCT BOX LABEL TO SAY "SYRINGE…
- US
P020023 · P020023/S009
Real-Time Process|Labeling Change - Indications/instructions/shelf life/tradename|APPROVAL FOR INCREASING THE EXPIRATION DATING FOR RESTYLAN…
- US
P020023 · P020023/S010
30-Day Notice|CHANGE OF LOCATION FOR A MANUFACTURING PROCESS.
- US
P020023 · P020023/S011
Special (Immediate Track)|Labeling Change - Indications/instructions/shelf life/tradename|APPROVAL FOR CHANGES IN PRODUCT LABELING.
- US
P020023 · P020023/S012
135 Review Track For 30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|APPROVAL FOR PERFORMING THE PROTEIN TESTING IN…
分开写首次批准、本证核发(延续或变更后会更新)、变更与有效期;首次批准为空表示未从官方来源取到。每张证只列最近 6 条变更,完整记录点编号看注册证原文。
交叉发现 · 价格观测
最近变化
5- P020023:135 Review Track For 30-Day Notice|Process Change - Manufacturer/Sterilizer/Pack…2005-10-21
- P020023:Special (Immediate Track)|Labeling Change - Indications/instructions/shelf life/…2005-03-11
- P020023:30-Day Notice|CHANGE OF LOCATION FOR A MANUFACTURING PROCESS.2004-09-17
- P020023:Real-Time Process|Labeling Change - Indications/instructions/shelf life/tradenam…2004-08-06
- P020023:Special (Immediate Track)|Labeling Change - Indications/instructions/shelf life/…2004-07-23